Print

Print


An interesting article which I just received:



Burns in MRI patients wearing transdermal patches

Because of the strong magnetic field created by the equipment during
magnetic resonance imaging (MRI), ferromagnetic metal objects can be
pulled by the magnet toward the patient on the scanner table at high
speed. In our October 3, 2001 issue, we wrote about the tragic death of a
6-year-old child in New York who suffered a skull fracture and
intracranial hemorrhage after an oxygen tank struck him. Prior to MRI,
patients are told to remove all metal objects they may be wearing, and
they are asked about the presence of any metal implants (e.g., pacemaker,
prosthetic hip, implanted intravenous port). Even retained bullets and
shrapnel, tattoos, and permanent eyeliner may create problems.

However, few people are aware that medication patches such as
ANDRODERM (testosterone), TRANSDERM-NITRO and DEPONIT
(nitroglycerin), HABITROL, NICODERM, and NICOTROL (nicotine),
TRANSDERM SCOP (scopolamine), CATAPRES-TTS (clonidine), and
possibly others, should also be removed prior to scanning.

Some patches are formulated with an aluminized backing that could
potentially cause injury to the patient if worn during an MRI procedure.

MRI systems require the use of radiofrequency (RF) pulses to create the
magnetic resonance signal. When conducting materials are placed within the
RF field, the result may be a concentration of electrical currents
sufficient to cause excessive heating and tissue damage. The metallic
component of these patches is nonferromagnetic and, therefore, not
attracted to the static magnetic field of an MRI system. However,
transdermal delivery systems with a metallic component are conductive and
can be heated.1

FDA is aware of two adverse events in which patients who were wearing a
nicotine transdermal patch during an MRI experienced burns. In the first
report, a patient entered an MRI scanner wearing a Habitrol 21 mg patch.

He started thrashing upon initiation of the third scanning cycle, and the
test was stopped immediately. When the patient was removed from the
magnet, he stated that his arm was burning. Upon examination, his upper
left arm was mildly erythematous and there was a small, denuded, blister
where the patch had been residing. In the second report, a patient
underwent a short (less than 40 seconds) MRI of the lumbar spine while
wearing a nicotine transdermal system patch. Later, the patient complained
of burn lines on his upper arms. In addition to these two cases, a
website, www.mrisafety.com, reports second degree burns when a patient
underwent an MRI with a Deponit patch in place.

Visit www.newmri.com/html/mr_safety.asp for a list of objects that cannot
be worn during an MRI. In light of these recent incidents, though, it
would be best to ask all patients about their use of any medication patch.
Unless it is certain that it doesn't contain metal, counsel patients to
remove the patch temporarily before an MRI to avoid unnecessary burns.

Thanks to pharmacists Linda Y. Kim-Jung, Carol Holquist, and Jerry
Phillips, of the Division of Medication Errors and Technical Support,
Office of Drug Safety, US FDA, for submitting this report.


===================================

Best,

Bob

**********************************************
Robert A. Fink, M. D., F.A.C.S., P. C.
2500 Milvia Street  Suite 222
Berkeley, California  94704-2636
Telephone:  510-849-2555   FAX:  510-849-2557
WWW:  http://www.rafink.com/

mailto:[log in to unmask]

"Ex Tristitia Virtus"

*********************************************

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn